Beck’s, the largest family-owned retail seed company in the United States, will establish a new soybean processing facility in New Madrid. The facility will help meet the growing demand for soybeans ...

Pre-specified Events to Trigger Interim Analysis of Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Remains on Track for Q4 2024 – – Data from the Phase 2a Trial of SLS009 in ...

Currently Corvus is enrolling patients in a registrational Phase 3 trial to evaluate soquelitinib to treat refractory ...

Last month, a second phase 3 blow for Marinus Pharmaceuticals prompted the Pennsylvania-based drugmaker to turn an eye toward ...

Eric Easom, the company's co-founder, chairman, president and chief executive officer, said recent data analysis indicate that epetraborole may provide clinical improvement in patients with ...

Reprioritized resources to reduce costs and enhance focus on Nana-val's development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) - - On track to report data ...

(Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated ... Phase 2 NAVAL-1 trial of Nana-val (nanatinostat in combination with ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat ... "In 2024, our Phase 3 data in status epilepticus and tuberous sclerosis complex showed ...

Syndax Pharmaceuticals announces positive Phase 2 trial results for revumenib in relapsed/refractory mNPM1 AML, with key ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...